Ebos Group Ltd (AU:EBO) — Market Cap & Net Worth
Market Cap & Net Worth: Ebos Group Ltd (EBO)
Ebos Group Ltd (AU:EBO) has a market capitalization of $2.45 Billion (AU$3.47 Billion) as of June 21, 2026. Listed on the AU stock exchange, this Australia-based company holds position #5659 globally and #135 in its home market, demonstrating a -1.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ebos Group Ltd's stock price AU$16.91 by its total outstanding shares 205038721 (205.04 Million). Review Ebos Group Ltd total liabilities to assess the company's total debt and financial obligations.
Ebos Group Ltd Market Cap History: 2015 to 2026
Ebos Group Ltd's market capitalization history from 2015 to 2026. Data shows growth from $1.40 Billion to $2.45 Billion (5.73% CAGR).
Index Memberships
Ebos Group Ltd is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$2.00 Trillion | 0.12% | #115 of 495 |
|
S&P/ASX 300
AXKO
|
$2.14 Trillion | 0.11% | #121 of 300 |
|
ASX Small Ordinaries
AXSO
|
$300.29 Billion | 0.82% | #37 of 200 |
Weight: Ebos Group Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ebos Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ebos Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.26x
Ebos Group Ltd's market cap is 0.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.80x
Ebos Group Ltd's market cap is 14.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.84 Billion | $7.10 Billion | $127.00 Million | 0.26x | 14.47x |
| 2017 | $2.00 Billion | $7.63 Billion | $132.85 Million | 0.26x | 15.03x |
| 2018 | $2.41 Billion | $7.61 Billion | $149.56 Million | 0.32x | 16.13x |
| 2019 | $2.91 Billion | $7.25 Billion | $144.07 Million | 0.40x | 20.22x |
| 2020 | $3.50 Billion | $9.38 Billion | $173.95 Million | 0.37x | 20.11x |
| 2021 | $5.13 Billion | $9.89 Billion | $199.09 Million | 0.52x | 25.78x |
| 2022 | $5.61 Billion | $11.90 Billion | $224.64 Million | 0.47x | 24.96x |
| 2023 | $4.62 Billion | $13.32 Billion | $275.74 Million | 0.35x | 16.74x |
| 2024 | $4.93 Billion | $14.41 Billion | $296.71 Million | 0.34x | 16.62x |
| 2025 | $3.43 Billion | $13.21 Billion | $231.66 Million | 0.26x | 14.80x |
Competitor Companies of EBO by Market Capitalization
Companies near Ebos Group Ltd in the global market cap rankings as of June 21, 2026.
Key companies related to Ebos Group Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #278 globally with a market cap of $90.23 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #538 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #636 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1166 globally with a market cap of $22.54 Billion USD ( AU$31.86 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #278 | McKesson Corporation | NYSE:MCK | $90.23 Billion | $750.63 |
| #538 | Cencora Inc. | NYSE:COR | $50.53 Billion | $271.83 |
| #636 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $221.77 |
| #1166 | Sigma Healthcare Ltd | AU:SIG | $22.54 Billion | AU$2.76 |
Ebos Group Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Ebos Group Ltd's market cap moved from $1.40 Billion to $ 2.45 Billion, with a yearly change of 5.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$2.45 Billion | -28.47% |
| 2025 | AU$3.43 Billion | -30.45% |
| 2024 | AU$4.93 Billion | +6.84% |
| 2023 | AU$4.62 Billion | -17.68% |
| 2022 | AU$5.61 Billion | +9.24% |
| 2021 | AU$5.13 Billion | +46.75% |
| 2020 | AU$3.50 Billion | +20.05% |
| 2019 | AU$2.91 Billion | +20.73% |
| 2018 | AU$2.41 Billion | +20.84% |
| 2017 | AU$2.00 Billion | +8.69% |
| 2016 | AU$1.84 Billion | +31.08% |
| 2015 | AU$1.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Ebos Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.45 Billion USD |
| MoneyControl | $2.45 Billion USD |
| MarketWatch | $2.45 Billion USD |
| marketcap.company | $2.45 Billion USD |
| Reuters | $2.45 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ebos Group Ltd
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligenc… Read more